YJL175W Antibody

What is YJL175W and why is it significant in yeast research?

The antibody against YJL175W is used to detect and study the protein products from this genomic region, specifically in Saccharomyces cerevisiae strain ATCC 204508/S288c . Understanding the interactions between YJL175W and SWI3 provides insights into gene regulation, chromatin remodeling, and transcriptional control in eukaryotic systems.

What are the recommended applications and experimental conditions for using YJL175W antibody?

The YJL175W antibody has been validated for specific research applications:

When using this antibody for experimental applications, maintain the following conditions:

• Store the antibody at -20°C or -80°C and avoid repeated freeze-thaw cycles

• Use the storage buffer provided (typically containing 50% Glycerol, 0.01M PBS at pH 7.4, and 0.03% Proclin 300 as preservative)

• For each experiment, include appropriate positive and negative controls to validate antibody performance

The antibody specifically reacts with Saccharomyces cerevisiae (strain ATCC 204508/S288c), so experimental designs should account for this species specificity .

How should I validate the specificity and sensitivity of YJL175W antibody for my research?

Validation is critical for ensuring reliable results with any antibody. For YJL175W antibody, follow these methodological steps:

• Specificity validation: Test the antibody on wild-type yeast and YJL175W/SWI3 deletion mutants. The antibody should recognize the protein in wild-type yeast but show altered or absent recognition in deletion strains .

• Sensitivity assessment: Create a serial dilution of your yeast lysate or use purified recombinant protein at known concentrations to determine the detection limit of the antibody . This helps establish the minimum amount of target protein required for reliable detection.

• Cross-reactivity testing: Test the antibody against related yeast strains to ensure it doesn't cross-react with unintended targets. This is particularly important when working with conserved proteins like those in the SWI/SNF complex .

• Reproducibility verification: Run your validated antibody on 20-40 samples under identical conditions but on different days to ensure consistent results . Also test different lots of the antibody when possible to assess lot-to-lot variability.

Remember that an antibody showing unexpected results (different molecular weights or expression patterns) compared to published literature should be thoroughly revalidated before use in critical experiments .

What controls should I include when using YJL175W antibody in my experiments?

Proper controls are essential for antibody-based experiments. For YJL175W antibody research, include:

• Positive control: Use lysate from wild-type S. cerevisiae (ATCC 204508/S288c strain) known to express the target protein .

• Negative control: Include lysate from a verified YJL175W deletion strain or SWI3 knockout strain, depending on your experimental question .

• Loading control: For western blots, include detection of a housekeeping protein (like actin) to normalize protein loading.

• Secondary antibody control: Run a sample with only secondary antibody (no primary YJL175W antibody) to identify potential non-specific binding of the secondary antibody.

• Isotype control: Include a non-specific IgG from the same species (rabbit) to identify potential non-specific binding .

Every experiment should include these controls to assess antibody performance and ensure reliable data interpretation. As noted in the literature, "Every experiment should include a positive and negative control to assess antibody performance, ideally a set of samples with variable expression levels of the protein of interest" .

How can YJL175W antibody be used to study the relationship between YJL175W deletion and SWI3 function?

The deletion of YJL175W creates a unique N-terminal truncation of the Swi3 protein (swi3∆N) that results in partial loss of function rather than complete elimination . To investigate this relationship:

• Comparative protein detection: Use the YJL175W antibody in western blots to compare protein expression and molecular weight between wild-type, YJL175W deletion, and SWI3 deletion strains. This helps identify the truncated Swi3 protein resulting from YJL175W deletion .

• Chromatin immunoprecipitation (ChIP): Combine YJL175W antibody with ChIP to examine how the N-terminal truncation affects Swi3 binding to chromatin targets. Compare binding profiles between wild-type and YJL175W deletion strains to identify differential binding patterns.

• Co-immunoprecipitation: Use YJL175W antibody for co-IP experiments to examine how the N-terminal truncation affects interactions between Swi3 and other components of the SWI/SNF complex. This provides insights into structural requirements for complex assembly.

• Immunofluorescence: Apply the antibody in immunofluorescence studies to examine potential changes in subcellular localization of the truncated Swi3 protein compared to wild-type.

Research has shown that YJL175W deletion results in transcriptional changes similar to but less pronounced than complete SWI3 deletion, with a correlation coefficient of 0.68 when comparing significantly changed transcripts . This suggests that the N-terminal region of Swi3 contributes to but is not solely responsible for its transcriptional regulatory functions.

What transcriptional changes occur in YJL175W deletion mutants and how can they be detected?

YJL175W deletion creates distinct transcriptional changes that can be investigated using the antibody in combination with other techniques:

• Gene-specific analysis: The YJL175W deletion primarily affects:

  • Decreased expression of highly expressed secreted proteins (77 out of 230 downregulated genes)

  • Decreased expression of transposon-related genes

  • Increased expression of methionine biosynthetic process genes

• Transcription factor changes: YJL175W deletion affects specific transcription factors:

• Detection methodology:

  • Use the antibody in ChIP-seq experiments to identify genome-wide binding patterns of the truncated Swi3 protein

  • Combine with RNA-seq to correlate binding with transcriptional changes

  • Use quantitative RT-PCR to validate changes in specific target genes

  • Employ reporter assays for key affected promoters to quantify transcriptional activity changes

Research has shown that the transcriptional change range is much wider in complete swi3Δ cells (standard deviation = 0.86) than in yjl175wΔ cells (standard deviation = 0.63), indicating that YJL175W deletion results in less pronounced but more selective transcriptional changes .

How does YJL175W deletion affect translation and protein burden effects in yeast?

YJL175W deletion creates unique effects on translation that can be studied using the antibody in combination with polysome profiling:

This suggests that YJL175W deletion creates a cellular state that can better accommodate protein overexpression by reallocating cellular resources. The hypothesized mechanism involves:

To study these effects:

• Use the antibody to detect changes in Swi3 protein levels and truncation

• Combine with polysome profiling to assess translational status

• Monitor growth rates and protein expression levels under various conditions

This research direction has significant implications for biotechnology applications requiring high protein expression in yeast systems.

What methodological considerations should be followed when using YJL175W antibody for chromatin immunoprecipitation studies?

When using YJL175W antibody for ChIP studies to investigate the role of Swi3 in chromatin remodeling:

• Crosslinking optimization: Determine the optimal crosslinking conditions (typically 1% formaldehyde for 10-15 minutes) specifically for the Swi3 protein, as chromatin remodelers can have different crosslinking requirements.

• Sonication parameters: Optimize sonication conditions to generate 200-500bp chromatin fragments without destroying epitope recognition. Test multiple sonication protocols while maintaining the integrity of the target protein.

• Antibody validation for ChIP: Validate the YJL175W antibody specifically for ChIP applications:

  • Perform a titration experiment using different amounts of antibody

  • Include a non-specific IgG control

  • Test enrichment at known SWI/SNF binding sites

  • Use SWI3 deletion strains as negative controls

• Sequential ChIP considerations: For studying co-occupancy with other SWI/SNF components, sequential ChIP (re-ChIP) requires:

  • Higher starting material amounts

  • Careful elution conditions to prevent denaturation of the second target

  • Use of compatible antibodies for the second immunoprecipitation

• Data analysis: When analyzing ChIP-seq data:

  • Compare wild-type and YJL175W deletion strains to identify differential binding sites

  • Focus on secreted protein genes and transposon-related regions based on known transcriptional changes

  • Correlate with RNA-seq data to identify functional binding events

Following these methodological considerations ensures reliable and reproducible ChIP results when studying the impact of YJL175W deletion on chromatin remodeling functions.

What are common issues when working with YJL175W antibody and how can they be resolved?

Researchers may encounter several challenges when working with YJL175W antibody:

• High background signal:

  • Potential causes: Insufficient blocking, high antibody concentration, cross-reactivity

  • Solutions: Optimize blocking conditions (try 5% BSA instead of milk for phospho-proteins), titrate antibody dilutions, include additional washing steps

• Weak or no signal:

  • Potential causes: Protein degradation, inefficient transfer, epitope masking

  • Solutions: Add protease inhibitors during sample preparation, optimize transfer conditions, try different epitope retrieval methods

• Multiple or unexpected bands:

  • Potential causes: Protein degradation, post-translational modifications, splice variants

  • Solutions: Use fresh samples with protease inhibitors, compare with literature on known modifications of Swi3, validate bands using knockout controls

• Batch-to-batch variability:

  • Potential causes: Different immunization responses, purification differences

  • Solutions: Test each new lot against a standard sample, maintain a reference sample for comparison

For reliable results, always run appropriate controls with every experiment as outlined in section 1.4.

How can I quantitatively assess changes in chromatin structure resulting from YJL175W deletion?

To quantitatively analyze chromatin structural changes resulting from YJL175W deletion:

• Nucleosome occupancy and methylome sequencing (NOMe-seq):

  • Combine with YJL175W antibody ChIP to correlate Swi3 binding with nucleosome positioning

  • Compare wild-type and YJL175W deletion strains to identify regions with altered chromatin accessibility

• ATAC-seq (Assay for Transposase-Accessible Chromatin):

  • Use to identify open chromatin regions genome-wide

  • Analyze differential accessibility between wild-type and YJL175W deletion strains

  • Correlate with YJL175W antibody ChIP-seq data to link Swi3 binding to accessibility changes

• Micrococcal Nuclease (MNase) sensitivity assay:

  • Treat chromatin with increasing amounts of MNase

  • Use YJL175W antibody to detect protected regions

  • Compare protection patterns between wild-type and deletion strains

• Quantitative analysis metrics:

  • Nucleosome Positioning Index (NPI)

  • Chromatin Accessibility Score

  • Binding Enrichment Ratio

Combining multiple approaches provides a comprehensive assessment of how YJL175W deletion affects chromatin structure through its impact on Swi3 function.

How might YJL175W antibody be used to understand the relationship between chromatin remodeling and protein burden effects?

The discovery that YJL175W deletion mitigates protein burden effects while partially affecting Swi3 function opens several research avenues:

• Mechanistic studies: Use YJL175W antibody to:

  • Identify specific chromatin regions where binding is altered by the N-terminal truncation

  • Compare these regions with promoters of highly expressed secreted proteins

  • Determine if selective binding affects transcription factor recruitment

• Biotechnology applications: Investigate how engineered Swi3 variants might:

  • Enhance protein production in industrial yeast strains

  • Improve tolerance to protein overexpression

  • Create customized expression patterns for synthetic biology applications

• Translational research: Explore parallels with cancer biology, as:

  • Mutations in the SWI/SNF complex are frequently observed in cancers

  • Understanding how partial loss of function affects resource allocation may provide insights into cancer cell metabolism

• Systems biology approach: Combine YJL175W antibody studies with:

  • Metabolomics to assess broader effects on cellular metabolism

  • Ribosome profiling to examine translation efficiency at specific mRNAs

  • Mathematical modeling to predict optimal Swi3 activity levels for various applications

This research could potentially lead to the development of engineered yeast strains with optimized resource allocation for biotechnology applications.

What new techniques might enhance the utility of YJL175W antibody in chromatin remodeling research?

Emerging technologies could significantly expand the research applications of YJL175W antibody:

• CUT&RUN or CUT&Tag:

  • Higher signal-to-noise ratio than traditional ChIP

  • Requires fewer cells and less antibody

  • Could provide more precise mapping of truncated Swi3 binding sites

• Proximity labeling (BioID or APEX):

  • Fuse BioID or APEX to Swi3 in wild-type and YJL175W deletion backgrounds

  • Use YJL175W antibody to confirm expression and localization

  • Identify differential protein interactions of truncated versus full-length Swi3

• Live-cell imaging:

  • Develop fluorescently labeled nanobodies derived from YJL175W antibody

  • Track Swi3 dynamics in living cells

  • Compare mobility and localization between wild-type and truncated variants

• Cryo-EM structural studies:

  • Use YJL175W antibody for immunoprecipitation to purify SWI/SNF complexes

  • Compare structures with wild-type versus truncated Swi3

  • Identify structural changes that explain functional differences

• Single-cell applications:

  • Adapt YJL175W antibody for single-cell CUT&Tag or similar techniques

  • Examine cell-to-cell variability in Swi3 binding

  • Correlate with single-cell transcriptomics

These technological advances would provide deeper insights into how N-terminal truncation of Swi3 affects chromatin remodeling and subsequent transcriptional outcomes.